CHEMICAL COMPOUNDS

The present invention describes novel compounds, or their pharmaceutically acceptable salts, pharmaceutical compositions containing them, and their medical uses. The compounds of the invention have activity as prostaglandin EP4 receptor antagonists, and are useful in the treatment or alleviation of...

Full description

Saved in:
Bibliographic Details
Main Authors BECK, Brent, OGBU, Cyprian, SPEAKE, Jason, PANDI, Bharathi
Format Patent
LanguageEnglish
French
Published 26.12.2019
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:The present invention describes novel compounds, or their pharmaceutically acceptable salts, pharmaceutical compositions containing them, and their medical uses. The compounds of the invention have activity as prostaglandin EP4 receptor antagonists, and are useful in the treatment or alleviation of pain and inflammation and other inflammation-associated disorders, such as arthritis, treating or preventing disorders or medical conditions selected from pain, inflammatory diseases and the like. Also described herein are methods of treating pain by administering the compounds of the invention, which are EP4 receptor antagonists. La présente invention concerne de nouveaux composés, ou leurs sels pharmaceutiquement acceptables, des compositions pharmaceutiques les contenant, et leurs utilisations médicales. Les composés selon l'invention ont une activité en tant qu'antagonistes du récepteur EP4 de la prostaglandine, et sont utiles dans le traitement ou le soulagement de la douleur, de l'inflammation et d'autres troubles associés à l'inflammation, tels que l'arthrite, le traitement ou la prévention de troubles ou d'états pathologiques choisis parmi la douleur, les maladies inflammatoires et analogues. L'invention concerne également des méthodes de traitement de la douleur par administration des composés selon l'invention, qui sont des antagonistes du récepteur EP4.
Bibliography:Application Number: WO2018US46162